"Wish bias" in antidepressant drug trials?

PubWeight™: 1.17‹?› | Rank: Top 10%

🔗 View Article (PMID 15206658)

Published in J Clin Psychopharmacol on April 01, 2004

Authors

Corrado Barbui1, Andrea Cipriani, Paolo Brambilla, Matthew Hotopf

Author Affiliations

1: Section of Psychiatry, Department of Medicine and Public Health, University of Verona, Verona, Italy. corrado.barbui@univr.it

Articles citing this

Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials. BMJ (2010) 4.98

Re-evaluation of the efficacy and tolerability of venlafaxine vs SSRI: meta-analysis. Psychopharmacology (Berl) (2007) 1.47

Fluoxetine versus other types of pharmacotherapy for depression. Cochrane Database Syst Rev (2005) 1.41

Escitalopram versus other antidepressive agents for depression. Cochrane Database Syst Rev (2009) 1.39

Changes in body weight and psychotropic drugs: a systematic synthesis of the literature. PLoS One (2012) 1.15

Duloxetine versus other anti-depressive agents for depression. Cochrane Database Syst Rev (2012) 0.90

Fluvoxamine versus other anti-depressive agents for depression. Cochrane Database Syst Rev (2010) 0.88

Citalopram versus other anti-depressive agents for depression. Cochrane Database Syst Rev (2012) 0.87

Milnacipran versus other antidepressive agents for depression. Cochrane Database Syst Rev (2009) 0.86

Comparing bona fide psychotherapies of depression in adults with two meta-analytical approaches. PLoS One (2013) 0.84

Venlafaxine versus other anti-depressive agents for depression. Cochrane Database Syst Rev (2007) 0.78

Paroxetine versus other anti-depressive agents for depression. Cochrane Database Syst Rev (2007) 0.76

When is standard treatment sufficiently active to make use of a placebo-controlled trial unethical? J Oncol Pract (2009) 0.75

Articles by these authors

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet (2013) 8.20

Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet (2012) 7.59

Prevalence of mental incapacity in medical inpatients and associated risk factors: cross-sectional study. Lancet (2004) 5.33

Mental capacity to make decisions on treatment in people admitted to psychiatric hospitals: cross sectional study. BMJ (2008) 3.99

Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. Lancet (2010) 3.72

What are the consequences of deployment to Iraq and Afghanistan on the mental health of the UK armed forces? A cohort study. Lancet (2010) 3.63

Imputing missing standard deviations in meta-analyses can provide accurate results. J Clin Epidemiol (2006) 3.30

Effectiveness of paroxetine in the treatment of acute major depression in adults: a systematic re-examination of published and unpublished data from randomized trials. CMAJ (2008) 3.27

Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat Genet (2013) 3.25

The South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLAM BRC) case register: development and descriptive data. BMC Psychiatry (2009) 3.15

The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology (Oxford) (2013) 3.07

Prevalence and predictors of mental incapacity in psychiatric in-patients. Br J Psychiatry (2005) 2.99

Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat Genet (2013) 2.92

The health status of nonparticipants in a population-based health study: the Hordaland Health Study. Am J Epidemiol (2010) 2.89

Suicide, depression, and antidepressants. BMJ (2005) 2.88

Mental capacity in psychiatric patients: Systematic review. Br J Psychiatry (2007) 2.62

Consent, confidentiality, and the Data Protection Act. BMJ (2006) 2.57

Assessing mental capacity: the Mental Capacity Act. BMJ (2008) 2.30

Outcome of major depression in Ethiopia: population-based study. Br J Psychiatry (2006) 2.29

Greater cortical gray matter density in lithium-treated patients with bipolar disorder. Biol Psychiatry (2007) 2.27

Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies. CMAJ (2009) 2.25

Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial. Lancet (2013) 2.23

Is there an Iraq war syndrome? Comparison of the health of UK service personnel after the Gulf and Iraq wars. Lancet (2006) 2.22

Mentally disordered or lacking capacity? Lessons for management of serious deliberate self harm. BMJ (2010) 2.17

A systematic review and meta-analysis of the pharmacological treatment of cancer-related fatigue. J Natl Cancer Inst (2008) 2.17

Patterns of drinking in the UK Armed Forces. Addiction (2007) 2.11

All-cause mortality among people with serious mental illness (SMI), substance use disorders, and depressive disorders in southeast London: a cohort study. BMC Psychiatry (2010) 2.08

Reliability of mental capacity assessments in psychiatric in-patients. Br J Psychiatry (2005) 2.07

Frequent attenders with medically unexplained symptoms: service use and costs in secondary care. Br J Psychiatry (2002) 2.04

Efficacy of antidepressants and benzodiazepines in minor depression: systematic review and meta-analysis. Br J Psychiatry (2011) 1.89

Perinatal exposure to low doses of dioxin can permanently impair human semen quality. Environ Health Perspect (2010) 1.87

Bias in psychiatric case-control studies: literature survey. Br J Psychiatry (2007) 1.83

Agomelatine efficacy and acceptability revisited: systematic review and meta-analysis of published and unpublished randomised trials. Br J Psychiatry (2013) 1.80

EMA must improve the quality of its clinical trial reports. BMJ (2011) 1.78

Evaluating complex interventions in end of life care: the MORECare statement on good practice generated by a synthesis of transparent expert consultations and systematic reviews. BMC Med (2013) 1.76

Does the addition of a second antipsychotic drug improve clozapine treatment? Schizophr Bull (2008) 1.70

The role of adiposity in cardiometabolic traits: a Mendelian randomization analysis. PLoS Med (2013) 1.70

Mental health screening in armed forces before the Iraq war and prevention of subsequent psychological morbidity: follow-up study. BMJ (2006) 1.66

Decision-making capacity for treatment in psychiatric and medical in-patients: cross-sectional, comparative study. Br J Psychiatry (2013) 1.62

Structural magnetic resonance imaging in bipolar disorder: an international collaborative mega-analysis of individual adult patient data. Biol Psychiatry (2010) 1.60

Ketamine and other glutamate receptor modulators for depression in adults. Cochrane Database Syst Rev (2015) 1.58

Serum dioxin concentrations and breast cancer risk in the Seveso Women's Health Study. Environ Health Perspect (2002) 1.57

Comparative epidemiology of chronic fatigue syndrome in Brazilian and British primary care: prevalence and recognition. Br J Psychiatry (2009) 1.57

Implementation of treatment guidelines for specialist mental health care. Cochrane Database Syst Rev (2014) 1.56

Aetiology of fatigue in Sri Lanka and its overlap with depression. Br J Psychiatry (2010) 1.54

Assisted suicide: why psychiatrists should engage in the debate. Br J Psychiatry (2011) 1.50

The mental health of UK Gulf war veterans: phase 2 of a two phase cohort study. BMJ (2002) 1.50

Incidence, prognosis, and risk factors for fatigue and chronic fatigue syndrome in adolescents: a prospective community study. Pediatrics (2007) 1.49

Chronic fatigue syndrome. BMJ (2010) 1.46

Antidepressants for the treatment of depression in people with cancer. Cochrane Database Syst Rev (2015) 1.45

Dioxin exposure, from infancy through puberty, produces endocrine disruption and affects human semen quality. Environ Health Perspect (2008) 1.45

Antidepressants for the treatment of depression in neurological disorders: a systematic review and meta-analysis of randomised controlled trials. J Neurol Neurosurg Psychiatry (2011) 1.43

Incidence of cancer among UK Gulf war veterans: cohort study. BMJ (2003) 1.43

'Goodbye and good luck': the mental health needs and treatment experiences of British ex-service personnel. Br J Psychiatry (2005) 1.42

Premorbid risk markers for chronic fatigue syndrome in the 1958 British birth cohort. Br J Psychiatry (2011) 1.40

Mental health consequences of overstretch in the UK armed forces: first phase of a cohort study. BMJ (2007) 1.40

Increased gray matter volume in lithium-treated bipolar disorder patients. Neurosci Lett (2002) 1.39

Cross-sectional study of abnormal amygdala development in adolescents and young adults with bipolar disorder. Biol Psychiatry (2004) 1.38

The prevalence of common mental disorders and PTSD in the UK military: using data from a clinical interview-based study. BMC Psychiatry (2009) 1.37

Disruption of white matter integrity in bipolar depression as a possible structural marker of illness. Biol Psychiatry (2011) 1.33

Smaller cingulate volumes in unipolar depressed patients. Biol Psychiatry (2006) 1.33

Childhood predictors of self reported chronic fatigue syndrome/myalgic encephalomyelitis in adults: national birth cohort study. BMJ (2004) 1.32

Identifying socio-demographic and socioeconomic determinants of health inequalities in a diverse London community: the South East London Community Health (SELCoH) study. BMC Public Health (2011) 1.32

Mental health and employment: much work still to be done. Br J Psychiatry (2009) 1.32

Shame! Self-stigmatisation as an obstacle to sick doctors returning to work: a qualitative study. BMJ Open (2012) 1.31

'Refusing treatment--please see': an analysis of capacity assessments carried out by a liaison psychiatry service. J R Soc Med (2004) 1.31

Imputing response rates from means and standard deviations in meta-analyses. Int Clin Psychopharmacol (2005) 1.30

Selective serotonin reuptake inhibitors. BMJ (2004) 1.28

Three-dimensional mapping of hippocampal anatomy in unmedicated and lithium-treated patients with bipolar disorder. Neuropsychopharmacology (2007) 1.27

Common mental disorders and disability pension award: seven year follow-up of the HUSK study. J Psychosom Res (2010) 1.27

Concentration-dependent TCDD elimination kinetics in humans: toxicokinetic modeling for moderately to highly exposed adults from Seveso, Italy, and Vienna, Austria, and impact on dose estimates for the NIOSH cohort. J Expo Anal Environ Epidemiol (2005) 1.26

Reduced left anterior cingulate volumes in untreated bipolar patients. Biol Psychiatry (2004) 1.26

Dioxin exposure and cancer risk in the Seveso Women's Health Study. Environ Health Perspect (2011) 1.26

Anatomical MRI study of hippocampus and amygdala in patients with current and remitted major depression. Psychiatry Res (2004) 1.26

Relationship of serum TCDD concentrations and age at exposure of female residents of Seveso, Italy. Environ Health Perspect (2004) 1.25

Cingulate cortex anatomical abnormalities in children and adolescents with bipolar disorder. Am J Psychiatry (2005) 1.23

The epidemiology of recurrent abdominal pain from 2 to 6 years of age: results of a large, population-based study. Pediatrics (2005) 1.22

Explanations for the increase in mental health problems in UK reserve forces who have served in Iraq. Br J Psychiatry (2007) 1.22

The stigma of mental health problems and other barriers to care in the UK Armed Forces. BMC Health Serv Res (2011) 1.22

Common and distinct neural correlates of emotional processing in Bipolar Disorder and Major Depressive Disorder: a voxel-based meta-analysis of functional magnetic resonance imaging studies. Eur Neuropsychopharmacol (2011) 1.21

Venlafaxine for major depression. BMJ (2007) 1.20

Long-term treatment of depression with antidepressants: a systematic narrative review. Can J Psychiatry (2007) 1.20

Anatomic evaluation of the orbitofrontal cortex in major depressive disorder. Biol Psychiatry (2004) 1.20

Co-occurring mental and substance abuse disorders: a review on the potential predictors and clinical outcomes. Psychiatry Res (2010) 1.19

Mental capacity and psychiatric in-patients: implications for the new mental health law in England and Wales. Br J Psychiatry (2009) 1.18

The contribution of prior psychological symptoms and combat exposure to post Iraq deployment mental health in the UK military. J Trauma Stress (2009) 1.18

Prevalence and characteristics of probable major depression and bipolar disorder within UK biobank: cross-sectional study of 172,751 participants. PLoS One (2013) 1.17

Antidepressants for depression in physically ill people. Cochrane Database Syst Rev (2010) 1.17

Associations between substance use disorder sub-groups, life expectancy and all-cause mortality in a large British specialist mental healthcare service. Drug Alcohol Depend (2011) 1.17

Etiology of chronic fatigue syndrome: testing popular hypotheses using a national birth cohort study. Psychosom Med (2008) 1.12

Three-dimensional mapping of hippocampal anatomy in adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry (2008) 1.12

Serum dioxin concentrations and endometriosis: a cohort study in Seveso, Italy. Environ Health Perspect (2002) 1.11

Drug therapy for the management of cancer-related fatigue. Cochrane Database Syst Rev (2010) 1.10

Usefulness of waist circumference for the identification of childhood hypertension. J Hypertens (2008) 1.10

Mild traumatic brain injury in UK military personnel returning from Afghanistan and Iraq: cohort and cross-sectional analyses. J Head Trauma Rehabil (2012) 1.10

Influence of childhood adversity on health among male UK military personnel. Br J Psychiatry (2007) 1.09

QT interval prolongation related to psychoactive drug treatment: a comparison of monotherapy versus polytherapy. Ann Gen Psychiatry (2005) 1.08

Serum uric acid and blood pressure in children at cardiovascular risk. Pediatrics (2013) 1.07